Biotricity Inc BTCY
About Quantitative Ratings
Morningstar Quantitative Ratings for Stocks are generated using an algorithm that compares companies that are not under analyst coverage to peer companies that do receive analyst-driven ratings. Companies with quantitative ratings are not formally covered by a Morningstar analyst, but are statistically matched to analyst-rated companies, allowing our models to calculate a quantitative moat, fair value, and uncertainty rating.
Trading Information
- Previous Close Price
- $1.15
- Day Range
- $1.16–1.51
- 52-Week Range
- $0.70–5.10
- Bid/Ask
- $1.31 / $1.43
- Market Cap
- $12.69 Mil
- Volume/Avg
- 564,681 / 95,528
Key Statistics
- Price/Earnings (Normalized)
- —
- Price/Sales
- 0.90
- Dividend Yield (Trailing)
- —
- Dividend Yield (Forward)
- —
- Total Yield
- —
Company Profile
Biotricity Inc is a medical technology company that focuses on biometric data monitoring solutions. It aims to deliver remote monitoring solutions to the healthcare & consumer markets, with a focus on diagnostic and post-diagnostic solutions for lifestyle and chronic illnesses. Biotricity is expanding medical-grade monitoring into the consumer market via its Biolife solution, which empowers users to self-manage chronic conditions. Its products include Bioflux, which is a mobile cardiac telemetry (MCT) device that provides real-time monitoring and transmission of ambulatory patients' ECG information; Biocare Telemed, which is a virtual clinic platform that enables clinicians to provide outstanding patient care remotely; Bioheart, which is a personal heart monitor; and Biocare health.
- Sector
- Healthcare
- Industry
- Medical Devices
- Stock Style Box
- Small Growth
- Total Number of Employees
- 55
- Website
- https://www.biotricity.com
Valuation
|
Metric
|
BTCY
|
|---|---|
Price/Earnings (Normalized) | — |
Price/Book Value | — |
Price/Sales | 0.90 |
Price/Cash Flow | — |
Price/Earnings
No chart available
Financial Strength
|
Metric
|
BTCY
|
|---|---|
Quick Ratio | 0.10 |
Current Ratio | 0.21 |
Interest Coverage | −1.92 |
Quick Ratio
BTCY
Profitability
|
Metric
|
BTCY
|
|---|---|
Return on Assets (Normalized) | −212.58% |
Return on Equity (Normalized) | — |
Return on Invested Capital (Normalized) | — |
Return on Assets
BTCY
Medical Devices Industry Comparables
|
Ticker
|
Name
|
Morningstar Rating for Stocks
|
Capital Allocation
|
Economic Moat
|
Market Cap
|
|---|---|---|---|---|---|
ABT
| Abbott Laboratories | Xvnxgzbq | Qsrcvw | $188.9 Bil | |
SYK
| Stryker Corp | Drrthhkp | Vjvt | $129.0 Bil | |
MDT
| Medtronic PLC | Zhxwcnnr | Lwqzv | $106.5 Bil | |
BSX
| Boston Scientific Corp | Vwdtnxy | Dwbxk | $100.9 Bil | |
EW
| Edwards Lifesciences Corp | Lddplbdpz | Nqfdcc | $53.7 Bil | |
DXCM
| DexCom Inc | Qpwtcpskg | Bkm | $51.9 Bil | |
ZBH
| Zimmer Biomet Holdings Inc | Cdhwtdrf | Bvsv | $25.5 Bil | |
ALGN
| Align Technology Inc | Lkysyfws | Nmqxmf | $24.7 Bil | |
PHG
| Koninklijke Philips NV ADR | Zljcswnqj | Pjslvt | $18.7 Bil | |
PODD
| Insulet Corp | Dcljycglf | Twfydzk | $12.3 Bil |